(Q54953858)

English

SK-MEL-170

cell line

SK-Mel-170
SKMEL-170

In more languages

default values for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

A molecular mechanism of complement resistance of human melanoma cells

1 reference

Cellosaurus release 49

14 July 2024

Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets

1 reference

Cellosaurus release 49

14 July 2024

Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF

1 reference

Cellosaurus release 49

14 July 2024

Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence

1 reference

Cellosaurus release 49

14 July 2024

Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54953858&oldid=2204568124"